A Mesenchymal Stromal Cell Gene Signature for Donor Age

Human aging is associated with loss of function and regenerative capacity. Human bone marrow derived mesenchymal stromal cells (hMSCs) are involved in tissue regeneration, evidenced by their capacity to differentiate into several lineages and therefore are considered the golden standard for cell-based regeneration therapy. Tissue maintenance and regeneration is dependent on stem cells and declines with age and aging is thought to influence therapeutic efficacy, therefore, more insight in the process of aging of hMSCs is of high interest. We, therefore, hypothesized that hMSCs might reflect signs of aging. In order to find markers for donor age, early passage hMSCs were isolated from bone marrow of 61 donors, with ages varying from 17–84, and clinical parameters, in vitro characteristics and microarray analysis were assessed. Although clinical parameters and in vitro performance did not yield reliable markers for aging since large donor variations were present, genome-wide microarray analysis resulted in a considerable list of genes correlating with human age. By comparing the transcriptional profile of aging in human with the one from rat, we discovered follistatin as a common marker for aging in both species. The gene signature presented here could be a useful tool for drug testing to rejuvenate hMSCs or for the selection of more potent, hMSCs for cell-based therapy.

[1]  A. Piastowska-Ciesielska,et al.  The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin , 2012, Journal of Bone and Mineral Metabolism.

[2]  Jeffrey R Stout,et al.  Acute loading and aging effects on myostatin pathway biomarkers in human skeletal muscle after three sequential bouts of resistance exercise. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[3]  S. Fazel,et al.  Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. , 2010, The Journal of thoracic and cardiovascular surgery.

[4]  A. Bergman,et al.  Genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians , 2009, Proceedings of the National Academy of Sciences.

[5]  C. V. van Blitterswijk,et al.  A link between the accumulation of DNA damage and loss of multi-potency of human mesenchymal stromal cells , 2009, Journal of cellular and molecular medicine.

[6]  Richard Weindruch,et al.  Gene expression profiling of aging in multiple mouse strains: identification of aging biomarkers and impact of dietary antioxidants , 2009, Aging cell.

[7]  A. Leusink,et al.  In vivo evaluation of highly macroporous ceramic scaffolds for bone tissue engineering. , 2009, Journal of biomedical materials research. Part A.

[8]  Wolfgang Wagner,et al.  Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells , 2009, PloS one.

[9]  R. Cawthon,et al.  Gene expression profiles associated with aging and mortality in humans , 2009, Aging cell.

[10]  M. Nagata,et al.  A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation. , 2009, Bone.

[11]  M. Kassem,et al.  Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. , 2009, Biochimica et biophysica acta.

[12]  A. Caplan Why are MSCs therapeutic? New data: new insight , 2009, The Journal of pathology.

[13]  Jeong-Sun Seo,et al.  Identification of senescence-associated genes in human bone marrow mesenchymal stem cells. , 2008, Biochemical and biophysical research communications.

[14]  W. Keith,et al.  Stem cell ageing: does it happen and can we intervene? , 2007, Expert Reviews in Molecular Medicine.

[15]  A. Uitterlinden,et al.  The FASEB Journal • Research Communication The activin A-follistatin system: potent regulator of human extracellular matrix mineralization , 2022 .

[16]  C. V. van Blitterswijk,et al.  Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  J. Rice,et al.  The influence of eccentric exercise on mRNA expression of skeletal muscle regulators , 2007, European Journal of Applied Physiology.

[18]  Chad A Shaw,et al.  Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation , 2007, PLoS biology.

[19]  G. Lockwood,et al.  High-level JAG1 mRNA and protein predict poor outcome in breast cancer , 2007, Modern Pathology.

[20]  Clemens A van Blitterswijk,et al.  Cell-Based Bone Tissue Engineering , 2007, PLoS medicine.

[21]  Clemens A van Blitterswijk,et al.  A rapid and efficient method for expansion of human mesenchymal stem cells. , 2007, Tissue engineering.

[22]  John F. Robinson,et al.  Ankyrin G overexpression in Hutchinson-Gilford progeria syndrome fibroblasts identified through biological filtering of expression profiles , 2006, Journal of Human Genetics.

[23]  Kevin G Becker,et al.  Transcriptional Profiling of Aging in Human Muscle Reveals a Common Aging Signature , 2006, PLoS genetics.

[24]  Claudio Franceschi,et al.  The Genetics of Human Longevity , 2006, Annals of the New York Academy of Sciences.

[25]  Zhenwei Pan,et al.  Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. , 2006, Biochemical and biophysical research communications.

[26]  Andrew Scutt,et al.  Aging of mesenchymal stem cells , 2006, Ageing Research Reviews.

[27]  Claes Wahlestedt,et al.  The expression signature of in vitro senescence resembles mouse but not human aging , 2005, Genome Biology.

[28]  I. Weissman,et al.  Rejuvenation of aged progenitor cells by exposure to a young systemic environment , 2005, Nature.

[29]  Lingli Wang,et al.  A Transcriptional Profile of Aging in the Human Kidney , 2004, PLoS biology.

[30]  I. Kohane,et al.  Gene regulation and DNA damage in the ageing human brain , 2004, Nature.

[31]  P. Lansdorp,et al.  Telomeres, telomerase, and hematopoietic stem cell biology. , 2003, Archives of medical research.

[32]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[33]  L. Kunkel,et al.  Life-long sustained mortality advantage of siblings of centenarians , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Hoeijmakers,et al.  Premature Aging in Mice Deficient in DNA Repair and Transcription , 2002, Science.

[35]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[36]  L. Giudice,et al.  Ovarian follicular concentrations of activin, follistatin, inhibin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. , 2000, The Journal of clinical endocrinology and metabolism.

[37]  P. Watkins,et al.  Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. , 1999, Experimental hematology.

[38]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[39]  A. Friedenstein,et al.  Bone marrow stromal colony formation requires stimulation by haemopoietic cells. , 1992, Bone and mineral.

[40]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[41]  D. Cameron-Smith,et al.  Impaired expression of Notch signaling genes in aged human skeletal muscle. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.

[42]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[43]  J. P. D. Magalhães Is mammalian aging genetically controlled? , 2004, Biogerontology.

[44]  R. Jilka,et al.  Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. , 2002, Endocrinology.